One-year results of the CRISTAL trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents

Journal of Interventional Cardiology

Volumn 25, Issue 6, 2012, Pages 586-595

  Chevalier, Bernard ^a   Moulichon, Robert ^b   Teiger, Emmanuel ^c   Brunel, Philippe ^d   Metzger, Jean Philippe ^e   Pansieri, Michel ^f   Carrie, Didier ^g   Stoll, Hans Peter ^h,i   Wittebols, Kristel ^h,i   Spaulding, Christian ^j   Fajadet, Jean ^k  

^a INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

^b Clinique Saint Pierre   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d Nouvelles Cliniques Nantaises Site Saint Henri   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f CENTRE HOSPITALIER D AVIGNON   (France)

^g CHU RANGUEIL   (France)

^h JOHNSON AND JOHNSON   (United States)

ⁱ Clinique Pasteur ^*

^j HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^k CLINIQUE PASTEUR   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; DRUG EFFICACY; DRUG ELUTING STENT; FEMALE; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; PACLITAXEL; SIROLIMUS;

EID: 84871269842     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2012.00769.x     Document Type: Article

References (27)

1. Morice MC, Serruys PW, Sousa JE, et al., A randomized comparison of a sirolimus eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
2. Moses JW, Leon MB, Popma JJ, et al., Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
3. Schampaert E, Cohen EA, Schluter M, et al., The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004; 43: 1110-1115.
4. Schofer J, Schluter M, Gershlick AH, et al., Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003; 362: 1093-1099.
5. Spaulding C, Daemen J, Boersma E, et al., A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007; 356: 989-997.
6. Alfonso F, Perez-Vizcayno MJ, Hernandez R, et al., A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: Results of the Restenosis Intrastent: Balloon angioplasty versus elective sirolimus-eluting stenting (RIBS-II) trial. J Am Coll Cardiol. 2006; 47: 2152-2160.
7. Kastrati A, Mehilli J, von Beckerath N, et al., Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: A randomized controlled trial. JAMA 2005; 293: 165-171.
8. Alfonso F, Perez-Vizcayno MJ, Hernandez R, et al., Sirolimus-eluting stents versus bare-metal stents in patients with in-stent restenosis: Results of a pooled analysis of two randomized studies. Catheter Cardiovasc Interv 2008; 72: 459-467.
9. Holmes DR Jr, Teirstein P, Satler L, et al,. Sirolimus eluting stents versus vascular brachytherapy for in-stent restenosis within bare-metal stents: The SISR randomized trial. JAMA. 2006; 295: 1264-1273.
10. Scheller B, Hehrlein C, Bocksch W, et al., Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006; 355: 2113-2124.
11. Rathore S, Kinoshita Y, Terashima , et al., A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents. EuroIntervention 2010; 5: 841-846.
12. Daemen J, Serruys PW,. Drug-eluting stent update 2007: Part I. A survey of current and future generation drug-eluting stents: Meaningful advances or more of the same Circulation 2007; 116: 316-328.
13. Daemen J, Serruys PW,. Drug-eluting stent update 2007: Part II: Unsettled issues. Circulation 2007; 116: 961-968.
14. Wijns W, Kolh P, Danchin N, et al., Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI). Guidelines on myocardial revascularization. Eur Heart J 2010; 31: 2501-2555.
15. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al., American College of Cardiology/American Heart Association Task Force on Practice Guidelines; ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006; 113: e166-286.
16. Cosgrave J, Melzi G, Biondi-Zoccai GG, et al., Drug-eluting stent restenosis the pattern predicts the outcome. J Am Coll Cardiol 2006; 47: 2399-2404.
17. Kitahara H, Kobayashi Y, Takebayashi H, et al., Re-restenosis and target lesion revascularization after treatment of sirolimus-eluting stent restenosis: Retrospective analysis of 4 Japanese hospitals. Circ J 2009; 73: 867-871.
18. Abe M, Kimura T, Morimoto T, et al., Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: Insights from the j-cypher registry. Circulation 2010; 122: 42-51.
19. Mehran R, Dangas G, Abizaid AS, et al., Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome. Circulation 1999; 100: 1872-1878.
20. Steinberg DH, Gaglia MA Jr, Pinto Slottow TL, et al,. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Am J Cardiol 2009; 103: 491-495.
21. Pocock SJ, Lansky AJ, Mehran R, et al., Angiographic surrogate end points in drug-eluting stent trials: A systematic evaluation based on individual patient data from 11 randomized, controlled trials. J Am Coll Cardiol 2008; 51: 23-32.
22. Block PC,. Restenosis after percutaneous transluminal coronary angioplasty-anatomic and pathophysiological mechanisms. Strategies for prevention. Circulation 1990; 81 (3 Suppl): IV2-4.
23. Serruys PW, Luijten HE, Beatt KJ, et al., Incidence of restenosis after successful coronary angioplasty: A time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 1988; 77: 361-371.
24. Mehilli J, Byrne RA, Tiroch K, et al., Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study. J Am Coll Cardiol 2010; 55: 2710-2716.
25. Unverdorben M, Vallbracht C, Cremers B, et al., Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 2009; 119: 2986-2994.
26. Habara S, Mitsudo K, Kadota K, et al., Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. JACC Cardiovasc Interv 2011; 4: 149-154.
27. Kang S-J, Mintz Gs, Park D-W, et al., Mechanisms of in-stent restenosis after drug-eluting stent implantation. Intravascular ultrasound analysis. Circ Cardiovasc Interv 2011; 4: 9-14.